MY8200056A - Absorbable hemostatic composition - Google Patents

Absorbable hemostatic composition

Info

Publication number
MY8200056A
MY8200056A MY56/82A MY8200056A MY8200056A MY 8200056 A MY8200056 A MY 8200056A MY 56/82 A MY56/82 A MY 56/82A MY 8200056 A MY8200056 A MY 8200056A MY 8200056 A MY8200056 A MY 8200056A
Authority
MY
Malaysia
Prior art keywords
hemostatic composition
absorbable hemostatic
absorbable
composition
hemostatic
Prior art date
Application number
MY56/82A
Other languages
English (en)
Inventor
Peter Lawrie
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of MY8200056A publication Critical patent/MY8200056A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A61F2310/00377—Fibrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
MY56/82A 1977-12-05 1982-12-30 Absorbable hemostatic composition MY8200056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB50503/77A GB1584080A (en) 1977-12-05 1977-12-05 Absorbable hemostatic composition

Publications (1)

Publication Number Publication Date
MY8200056A true MY8200056A (en) 1982-12-31

Family

ID=10456141

Family Applications (1)

Application Number Title Priority Date Filing Date
MY56/82A MY8200056A (en) 1977-12-05 1982-12-30 Absorbable hemostatic composition

Country Status (10)

Country Link
CA (1) CA1119515A (enExample)
DE (1) DE2852319A1 (enExample)
FR (1) FR2410477A1 (enExample)
GB (1) GB1584080A (enExample)
HK (1) HK34681A (enExample)
HU (1) HU179969B (enExample)
IE (1) IE47606B1 (enExample)
IL (1) IL56110A (enExample)
IN (1) IN149490B (enExample)
MY (1) MY8200056A (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981000516A1 (fr) * 1979-08-31 1981-03-05 Merck Patent Gmbh Gel contenant fibrine et antibiotique pour le traitement d'os infectes et son procede de preparation
EP0030583B1 (de) * 1979-12-18 1984-06-13 Oscobal Ag Knochenersatzmaterial und Verfahren zur Herstellung eines Knochenersatzmaterials
DE3014123C2 (de) * 1980-04-12 1982-03-18 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur Herstellung von Skleroproteintransplantaten mit erhöhter biologischer Stabilität
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US4440789A (en) * 1982-11-16 1984-04-03 Ethicon, Inc. Synthetic absorbable hemostatic composition
USRE32208E (en) * 1982-11-16 1986-07-15 Ethicon, Inc. Absorbable hemostatic composition
US4439420A (en) * 1982-11-16 1984-03-27 Ethicon, Inc. Absorbable hemostatic composition
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
EP0115549B1 (de) * 1983-02-03 1987-11-25 Ethicon, Inc. Paste zur Blutstillung und temporären Defektüberbrückung bei Knochentrauma
EP0166263A1 (en) * 1984-05-31 1986-01-02 Green Cross Corporation Filler composition for filling in defect or hollow portion of bone and kit or set for the preparation of the filler composition
JPS61122222A (ja) * 1984-11-19 1986-06-10 Koken:Kk コラ−ゲン又はゼラチンとプロタミンとよりなる止血剤
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
AU2572692A (en) 1991-09-09 1993-04-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and devices for treating hemophilia and aids
GB9211432D0 (en) * 1992-05-29 1992-07-15 Jevco Ltd Absorbable bone sealant
US5696101A (en) * 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
US6117444A (en) * 1997-04-10 2000-09-12 Brigham & Women's Hospital Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
DE19858891A1 (de) * 1998-12-19 2000-06-21 Merck Patent Gmbh Verbesserte Knochensiegel
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
JP4777650B2 (ja) 2002-09-10 2011-09-21 アメリカン ナショナル レッド クロス 止血用包帯
CA2509914A1 (en) 2002-12-11 2004-06-24 Ferrosan A/S Gelatine-based materials as swabs
CN102579162A (zh) 2003-09-23 2012-07-18 奥索康公司 可吸收的植入体和它们用于止血和治疗骨缺损的方法
US7955616B2 (en) 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
AU2004279320A1 (en) 2003-09-23 2005-04-21 Ortho Therapeutics, Llc. Bioabsorbable putty-like hemostatic implants
DE10357460A1 (de) * 2003-12-04 2005-07-07 Friedrich-Baur-Gmbh Bioresorbierbares Material
AR054637A1 (es) * 2004-01-30 2007-07-11 Ferrosan As Aerosoles y composiciones hemostaticas
CN101001649B (zh) 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
US8603528B2 (en) 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
US8506646B2 (en) 2005-04-29 2013-08-13 Warsaw Orthopedic, Inc. Multi-purpose medical implant devices
US8092464B2 (en) 2005-04-30 2012-01-10 Warsaw Orthopedic, Inc. Syringe devices and methods useful for delivering osteogenic material
US8445009B2 (en) 2006-08-04 2013-05-21 Stb, Ltd Processes for the production of solid dressings for treating wounded tissue
US20090075891A1 (en) 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
US20100331254A1 (en) * 2007-12-26 2010-12-30 Metamorefix Pulverized fibrin clots and pharmaceutical compositions containing them
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
DE202010009512U1 (de) 2010-05-28 2011-01-13 Hfp Ingredients B.V. Collagenpulver
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
EP3010419B1 (en) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN108261560B (zh) * 2017-01-03 2020-12-08 张家港唯瀚生物科技有限公司 一种含变性淀粉纳米粒的可降解吸收止血材料及其应用
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
CN113144277B (zh) * 2021-04-13 2022-06-14 武汉理工大学 一种可注射流体明胶及其制备方法和应用
CN114470307B (zh) * 2022-04-06 2022-06-24 天新福（北京）医疗器材股份有限公司 一种可降解止血封堵胶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772999A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical compositions and dressings
FR1325128A (fr) * 1962-03-26 1963-04-26 Procédé de préparation de bioplastes utilisables comme prothèses résorbables
US3523807A (en) * 1966-11-25 1970-08-11 Mihaly Gerendas Method of making a cross-linked fibrin prosthesis
US3742955A (en) * 1970-09-29 1973-07-03 Fmc Corp Fibrous collagen derived product having hemostatic and wound binding properties
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars

Also Published As

Publication number Publication date
IL56110A (en) 1981-09-13
IN149490B (enExample) 1981-12-26
HK34681A (en) 1981-07-24
FR2410477A1 (fr) 1979-06-29
IE47606B1 (en) 1984-05-02
IE782393L (en) 1979-06-05
IL56110A0 (en) 1979-03-12
GB1584080A (en) 1981-02-04
DE2852319C2 (enExample) 1990-08-16
DE2852319A1 (de) 1979-06-07
FR2410477B1 (enExample) 1981-11-13
HU179969B (en) 1983-01-28
CA1119515A (en) 1982-03-09

Similar Documents

Publication Publication Date Title
IL56110A (en) Absorbable hemostatic compositions
JPS5457391A (en) Hemostatic device
JPS5476831A (en) Antiibacterial composition
ZA782595B (en) Ostomy composition
JPS5495648A (en) Composition
JPS55111413A (en) Composition for mouthcavity
GB2005139A (en) Carpet-treating composition
JPS5470286A (en) Antiimalaria composition
PT67750A (en) Composition
JPS53130747A (en) Photosensitine composition
GB2014126B (en) Composition
JPS5433541A (en) Rusttpreventive composition
JPS5444020A (en) Novel composition
JPS542341A (en) Medical composition
JPS53121731A (en) Novel composition
AU517229B2 (en) Absorbable polymer-drug compositions
JPS5428829A (en) Antiithrombosis medical composition
AU526216B2 (en) Chemically modified collagen hemostatic agent
JPS5452732A (en) Diagnostic composition
AU3228078A (en) Anti-helmintic composition
JPS5417991A (en) Photoopolymerizable composition
JPS5396332A (en) Antiiglaucoma composition
JPS54100453A (en) Composition
JPS5464641A (en) Antiibacterial composition
JPS5430A (en) Composition